Mezzion Pharma Co.Ltd (140410) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.391x

Based on the latest financial reports, Mezzion Pharma Co.Ltd (140410) has a cash flow conversion efficiency ratio of -0.391x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-6.07 Billion ≈ $-4.11 Million USD) by net assets (₩15.51 Billion ≈ $10.51 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Mezzion Pharma Co.Ltd for the company's overall valuation and market capitalisation.

Mezzion Pharma Co.Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Mezzion Pharma Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Mezzion Pharma Co.Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Mezzion Pharma Co.Ltd ranked by their cash flow conversion efficiency. Explore Mezzion Pharma Co.Ltd (140410) cash earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Tecnon Fujian Commercial Lighting Co Ltd SHE:300650	-0.166x
PCL Technologies Inc TW:4977	0.004x
Trade-Van Information Services Co TW:6183	0.038x
Zhejiang Jianfeng Group Co Ltd SHG:600668	0.022x
Summit Midstream Corporation NYSE:SMC	0.008x
Posiflex Technology Inc TW:8114	-0.061x
Huchems KO:069260	0.030x
John Wiley & Sons B NYSE:WLYB	0.185x

Annual Cash Flow Conversion Efficiency for Mezzion Pharma Co.Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Mezzion Pharma Co.Ltd from 2012 to 2025. View latest Mezzion Pharma Co.Ltd stock price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩17.19 Billion ≈ $11.65 Million	₩-16.59 Billion ≈ $-11.24 Million	-0.965x	-140.34%
2024-12-31	₩46.06 Billion ≈ $31.22 Million	₩-18.49 Billion ≈ $-12.53 Million	-0.401x	-123.74%
2023-12-31	₩61.44 Billion ≈ $41.64 Million	₩-11.02 Billion ≈ $-7.47 Million	-0.179x	+61.01%
2022-12-31	₩26.24 Billion ≈ $17.78 Million	₩-12.07 Billion ≈ $-8.18 Million	-0.460x	-91.72%
2021-12-31	₩62.79 Billion ≈ $42.55 Million	₩-15.07 Billion ≈ $-10.21 Million	-0.240x	-84.84%
2020-12-31	₩56.81 Billion ≈ $38.50 Million	₩-7.38 Billion ≈ $-5.00 Million	-0.130x	+73.36%
2019-12-31	₩42.83 Billion ≈ $29.03 Million	₩-20.88 Billion ≈ $-14.15 Million	-0.488x	-28.63%
2018-12-31	₩57.32 Billion ≈ $38.84 Million	₩-21.72 Billion ≈ $-14.72 Million	-0.379x	-52.50%
2017-12-31	₩53.17 Billion ≈ $36.03 Million	₩-13.21 Billion ≈ $-8.95 Million	-0.249x	-115.96%
2016-12-31	₩52.81 Billion ≈ $35.79 Million	₩-6.08 Billion ≈ $-4.12 Million	-0.115x	-506.08%
2015-12-31	₩62.54 Billion ≈ $42.38 Million	₩1.77 Billion ≈ $1.20 Million	0.028x	-42.77%
2012-12-31	₩63.34 Billion ≈ $42.92 Million	₩3.14 Billion ≈ $2.13 Million	0.050x	--

About Mezzion Pharma Co.Ltd

KQ:140410 Korea Pharmaceuticals

Market Cap

$429.17 Million

₩633.28 Billion KRW

Market Cap Rank

#13136 Global

#378 in Korea

Share Price

₩74100.00

Change (1 day)

+2.77%

52-Week Range

₩51000.00 - ₩172700.00

All Time High

₩172700.00